National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

liposomal daunorubicin citrate
A liposome-encapsulated form of the citrate salt of the anthracycline antineoplastic antibiotic daunorubicin. Daunorubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. Liposomal delivery of doxorubicin citrate improves drug penetration into tumors and decreases drug clearance, thereby increasing the duration of therapeutic drug effects. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:daunorubicin liposomal
liposomal daunorubicin
US brand name:DaunoXome



Previous:Lipitor, Lipo-Lutin, LipoDox, liposomal amphotericin B, liposomal cytarabine
Next:liposomal NDDP, liposome-encapsulated doxorubicin citrate, lipsomal cytarabine-daunorubicin CPX-351, Liquid Pred, Lisacort

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov